Cocrystal Pharma Inc Stock OTC Bulletin Board
Equities
US19188J1025
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 27.06M 37.06M |
---|---|---|---|---|---|
Net income 2024 * | -20M -27.39M | Net income 2025 * | -24M -32.87M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.4
x | P/E ratio 2025 * |
-1.34
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 69.97% |
Managers | Title | Age | Since |
---|---|---|---|
Sam Lee
CEO | Chief Executive Officer | 64 | 14-01-01 |
James Martin
CEO | Chief Executive Officer | 57 | 17-02-22 |
Roger Kornberg
CHM | Chairman | 76 | 14-01-01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Phillip Frost
BRD | Director/Board Member | 87 | 14-01-01 |
Director/Board Member | 68 | 21-05-26 | |
Steven Rubin
BRD | Director/Board Member | 63 | 14-01-01 |
1st Jan change | Capi. | |
---|---|---|
+15.19% | 121B | |
+19.91% | 114B | |
+8.24% | 23.61B | |
-19.80% | 20.43B | |
-16.19% | 16.55B | |
-13.45% | 16.45B | |
-44.35% | 15.59B | |
+2.13% | 13.54B | |
+66.67% | 15.19B |